Castle Biosciences, Inc. · 22 hours ago
Reimbursement, RCM Quality Auditor (FWD)
Castle Biosciences Inc. is a growing company recognized as a 'Top Workplaces USA Award' winner. They are seeking a full-time RCM Quality Auditor to perform quality audits of pre-billing, billing, and appeal tasks, ensuring compliance with procedures and guidelines while collaborating with the RCM Training team to support performance improvements.
BiotechnologyHealth CareHealth Diagnostics
Responsibilities
Performing quality audits of pre-billing, billing, and appeal tasks to ensure compliance with standard operating procedures and payer guidelines
Documenting audit findings, tracking quality metrics, and delivering regular QA results to Reimbursement Management
Analyzing trends and root causes to recommend corrective actions and process improvements
Collaborating closely with the RCM Training team to address knowledge gaps and support performance improvement plans as needed
Contributing to the development and maintenance of SOPs and QA documentation
Preparing audit reports and providing weekly activity updates
Completing ad hoc audits or projects assigned by management
Qualification
Required
Five years + of experience in a revenue cycle management role
Two years + of experience performing Quality audits in a revenue cycle management environment
Proven track record of consistently applying policies and procedures in a healthcare billing environment
Extensive knowledge of all tasks within the health insurance billing process
Knowledge of healthcare compliance regulations, such as HIPAA, Medicare, Medicaid, and commercial payer guidelines
Typing speed of 35 or more words per minute, with 90% or greater accuracy
All candidates must be legally authorized to work in the United States
Benefits
Excellent Annual Salary + 20% Bonus Potential
20 Accrued PTO Days Annually
10 Paid Holidays
401K with 100% Company Match up to 6%
3 Health Care Plan Options + Company HSA Contribution
Company Stock Grant Upon Hire
Company
Castle Biosciences, Inc.
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care.
Funding
Current Stage
Public CompanyTotal Funding
$427.33MKey Investors
BrightEdge FundIndustry VenturesHealthQuest Capital
2020-12-15Post Ipo Equity· $266.8M
2020-06-24Post Ipo Equity· $74M
2019-07-24Series Unknown
Recent News
GlobeNewswire
2026-01-12
Company data provided by crunchbase